Cargando…

L-lysine as adjunctive treatment in patients with schizophrenia: a single-blinded, randomized, cross-over pilot study

BACKGROUND: Accumulating evidence suggests that the brain's nitric oxide (NO) signalling system may be involved in the pathophysiology of schizophrenia and could thus constitute a novel treatment target. The study was designed to investigate the benefit of L-lysine, an amino acid that interfere...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wass, Caroline, Klamer, Daniel, Katsarogiannis, Evangelos, Pålsson, Erik, Svensson, Lennart, Fejgin, Kim, Bogren, Inga-Britt, Engel, Jörgen A, Rembeck, Birgitta
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094237/ https://www.ncbi.nlm.nih.gov/pubmed/21501494 http://dx.doi.org/10.1186/1741-7015-9-40

Ejemplares similares

Single-blind, randomized controlled trial of effectiveness of Naikan therapy as an adjunctive treatment for schizophrenia over a one-year follow-up period
por: ZHANG, Hong, et al.
Publicado: (2015)

Adjunctive antidepressive pharmacotherapy in schizophrenia patients
por: Zink, M.
Publicado: (2021)

N-acetylcysteine as an adjunct treatment of schizophrenia
por: Freitas, R. Mota, et al.
Publicado: (2021)

Vortioxetine as adjunctive therapy in the treatment of schizophrenia
por: Redaelli, Sofia, et al.
Publicado: (2022)

Adjunctive treatment for cognitive impairment in patients with chronic schizophrenia: a double-blind, placebo-controlled study
por: Zhu, Weiwei, et al.
Publicado: (2014)

15q13.3 homozygous knockout mouse model display epilepsy-, autism- and schizophrenia-related phenotypes
por: Forsingdal, A, et al.
Publicado: (2016)

Pentoxifylline as an adjunctive in treatment of negative symptoms in chronic schizophrenia: A double‐blind, randomized, placebo‐controlled trial
por: Abdallah, Mahmoud S., et al.
Publicado: (2022)

Progressive Multifocal Leukoencephalopathy and Systemic Lupus Erythematosus: Focus on Etiology
por: Berntsson, Shala Ghaderi, et al.
Publicado: (2016)

Resveratrol Adjunct Therapy for Negative Symptoms in Patients With Stable Schizophrenia: A Double-Blind, Randomized Placebo-Controlled Trial
por: Samaei, Areoo, et al.
Publicado: (2020)

Functional Hallucinations in Schizophrenia Responding to Adjunctive Sodium Valproate
por: Rajkumar, Ravi Philip
Publicado: (2012)

Raloxifene adjunctive therapy for postmenopausal women suffering from chronic schizophrenia: a randomized double-blind and placebo controlled trial
por: Kianimehr, Gilda, et al.
Publicado: (2014)

Efficacy of Spironolactone as an Adjunctive Therapy to Risperidone to Improve Symptoms of Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled, Clinical Trial
por: Zandifar, Atefeh, et al.
Publicado: (2022)

Effects of Adjunctive Betahistine Therapy on Lipid Metabolism in Patients with Chronic Schizophrenia: A Randomized Double-Blind Placebo-Controlled Study
por: Bai, Luyuan, et al.
Publicado: (2023)

The Direct and Long-Term Effects of Raloxifene as Adjunctive Treatment for Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Clinical Trial
por: Brand, Bodyl A, et al.
Publicado: (2023)

Absence of Oligoclonal Bands in Multiple Sclerosis: A Call for Differential Diagnosis
por: Katsarogiannis, Evangelos, et al.
Publicado: (2023)

Nutritional interventions for the adjunctive treatment of schizophrenia: a brief review
por: Arroll, Megan Anne, et al.
Publicado: (2014)

Minocycline as adjunct therapy for a male patient with deficit schizophrenia
por: Chen, Xiaohua, et al.
Publicado: (2018)

Is Memantine Effective as an NMDA Receptor Antagonist in Adjunctive Therapy for Schizophrenia?
por: Kikuchi, Tetsuro
Publicado: (2020)

Adjunctive Magnetic Seizure Therapy for Schizophrenia: A Systematic Review
por: Zhang, Xin-Yang, et al.
Publicado: (2022)

Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial
por: Raqib, Rubhana, et al.
Publicado: (2012)

Return to work after a workplace-oriented intervention for patients on sick-leave for burnout - a prospective controlled study
por: Karlson, Björn, et al.
Publicado: (2010)

Blockade of growth hormone secretagogue receptor 1A signaling by JMV 2959 attenuates the NMDAR antagonist, phencyclidine-induced impairments in prepulse inhibition
por: Engel, Jörgen A., et al.
Publicado: (2015)

Adjunctive raloxifene treatment improves attention and memory in men and women with schizophrenia
por: Weickert, T W, et al.
Publicado: (2015)

Adjunctive Melatonin for Tardive Dyskinesia in Patients with Schizophrenia: A Meta-Analysis
por: NG, Chee H., et al.
Publicado: (2017)

Altered brainstem responses to modafinil in schizophrenia: implications for adjunctive treatment of cognition
por: Minzenberg, Michael J., et al.
Publicado: (2018)

Meta-analysis of the Efficacy and Safety of Adjunctive Rosuvastatin for Dyslipidemia in Patients with Schizophrenia
por: UNGVARI, Gabor S., et al.
Publicado: (2018)

The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia
por: Ashton, Melanie M., et al.
Publicado: (2019)

Recycling N-acetylcysteine: A review of evidence for adjunctive therapy in schizophrenia
por: Willborn, Robert J., et al.
Publicado: (2019)

Repetitive transcranial magnetic stimulation as an adjunctive treatment for negative symptoms and cognitive impairment in patients with schizophrenia: a randomized, double-blind, sham-controlled trial
por: Zhuo, Kaiming, et al.
Publicado: (2019)

Protocol and Rationale: A 24-week Double-blind, Randomized, Placebo Controlled Trial of the Efficacy of Adjunctive Garcinia mangostana Linn. (Mangosteen) Pericarp for Schizophrenia
por: Turner, Alyna, et al.
Publicado: (2019)

S53. COMPARISON OF RALOXIFENE AND ISRADIPINE AS AN ADJUNCTIVE TREATMENT IN COGNITIVE DEFICITS OF PATIENTS WITH SCHIZOPHRENIA
por: Vahdani, Bita, et al.
Publicado: (2018)

T210. REVIEW OF USE OF ADJUNCTIVE PSYCHOSTIMULANTS IN PATIENTS WITH SCHIZOPHRENIA: A RETROSPECTIVE STUDY
por: Zhand, Naista, et al.
Publicado: (2020)

Base rates, blindness, and schizophrenia
por: Silverstein, Steven M., et al.
Publicado: (2013)

A double-blind randomized study assessing safety and efficacy following one-year adjunctive treatment with bitopertin, a glycine reuptake inhibitor, in Japanese patients with schizophrenia
por: Hirayasu, Yoshio, et al.
Publicado: (2016)

The safety and efficacy of adjunctive 20-Hz repetitive transcranial magnetic stimulation for treatment of negative symptoms in patients with schizophrenia: A double-blinded, randomized, sham-controlled study
por: Singh, Swarndeep, et al.
Publicado: (2020)

Group art therapy as an adjunctive treatment for people with schizophrenia: multicentre pragmatic randomised trial
por: Crawford, Mike J, et al.
Publicado: (2012)

Gabapentin adjunctive to risperidone or olanzapine in partially responsive schizophrenia: an open-label pilot study
por: Gabriel, Adel
Publicado: (2010)

Randomized controlled trial on adjunctive cognitive remediation therapy for chronically hospitalized patients with schizophrenia
por: Lu, Hongbo, et al.
Publicado: (2012)

Spotlight on brexpiprazole and its potential in the treatment of schizophrenia and as adjunctive therapy for the treatment of major depression
por: Bruijnzeel, Dawn, et al.
Publicado: (2016)

Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On Trials
por: Marini, Stefano, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4nb2ljq1o38tp09ebdpscis2g8